H. Sengeløv

C. Mølgaard, D. Burrin, H. Sengeløv, 2019, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Insulin-Like Growth Factor Gene Polymorphisms Predict Clinical Course in Allogeneic Hematopoietic Stem Cell Transplantation

H. Sengeløv, A. Juul, K. Müller, 2020, Frontiers in Immunology.

ADP-ribosylation-factor-regulated phospholipase D activity localizes to secretory vesicles and mobilizes to the plasma membrane following N-formylmethionyl-leucyl-phenylalanine stimulation of human neutrophils.

H. Sengeløv, S. Cockcroft, C. Morgan, 1997, The Biochemical journal.

Azurophilic Granules of Human Neutrophilic Leukocytes Are Deficient in Lysosome-Associated Membrane Proteins but Retain the Mannose 6-Phosphate Recognition Marker

H. Sengeløv, L. Kjeldsen, J. August, 1998 .

Inter-relationships between single carbon units' metabolism and resting energy expenditure in weight-losing patients with small cell lung cancer. Effects of methionine supply and chemotherapy.

J. Bülow, H. Sengeløv, L. Simonsen, 1994, European Journal of Cancer.

Glucose-induced thermogenesis in patients with small cell lung carcinoma. Before and after inhibition of tumour growth by chemotherapy.

J. Bülow, H. Sengeløv, J. Madsen, 1993, Clinical physiology.

Stimulus-dependent secretion of plasma proteins from human neutrophils.

H. Sengeløv, L. Kjeldsen, A. Johnsen, 1992, The Journal of clinical investigation.

Identification of the novel HLA allele, HLA‐DPA1*01:46, identified in a man of Serbian origin

H. Sengeløv, H. Bruunsgaard, A. Hauge, 2021, HLA.

High preharvest donor Foxp3 mRNA level predicts late relapse of acute lymphoblastic leukaemia after haematopoietic stem cell transplantation

N. Keiding, H. Sengeløv, M. Andersen, 2021, European journal of haematology.

Subcellular fractionation of human neutrophils on Percoll density gradients.

H. Sengeløv, L. Kjeldsen, N. Borregaard, 1999, Journal of immunological methods.

The clinical utility of FDG PET/CT among solid organ transplant recipients suspected of malignancy or infection

J. Lundgren, H. Sengeløv, H. Johannesen, 2016, European Journal of Nuclear Medicine and Molecular Imaging.

Allogeneic hematopoietic stem-cell transplantation for acute myeloid leukemia in remission: comparison of intravenous busulfan plus cyclophosphamide (Cy) versus total-body irradiation plus Cy as conditioning regimen--a report from the acute leukemia working party of the European group for blood and

M. Labopin, I. Yakoub-Agha, H. Sengeløv, 2013, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Pretransplant C‐reactive Protein as A Prognostic Marker in Allogeneic Stem Cell Transplantation

I. Christensen, H. Sengeløv, C. Heilmann, 2014, Scandinavian journal of immunology.

T cell Reconstitution in Allogeneic Haematopoietic Stem Cell Transplantation: Prognostic Significance of Plasma Interleukin‐7

H. Sengeløv, C. Nielsen, L. Ryder, 2015, Scandinavian journal of immunology.

Functional immune reconstitution early after allogeneic haematopoietic cell transplantation: A comparison of pre‐ and post‐transplantation cytokine responses in stimulated whole blood

H. Sengeløv, S. Ostrowski, L. Friis, 2021, Scandinavian journal of immunology.

Lysozyme in human neutrophils and plasma. A parameter of myelopoietic activity.

H. Sengeløv, L. Kjeldsen, N. Borregaard, 1995, Leukemia.

The prevalence and prognostic value of concomitant eosinophilia in chronic graft-versus-host disease after allogeneic stem cell transplantation.

H. Sengeløv, T. Gerds, C. Andersen, 2014, Leukemia research.

Subcellular distribution of docking/fusion proteins in neutrophils, secretory cells with multiple exocytic compartments.

S. Grinstein, H. Sengeløv, A. Klip, 1995, Journal of immunology.

Azurophilic granules of human neutrophilic leukocytes are deficient in lysosome-associated membrane proteins but retain the mannose 6-phosphate recognition marker.

H. Sengeløv, L. Kjeldsen, J. August, 1998, Blood.

Metabolic Potential of the Gut Microbiome Is Significantly Impacted by Conditioning Regimen in Allogeneic Hematopoietic Stem Cell Transplantation Recipients

J. Lundgren, H. Sengeløv, C. MacPherson, 2022, International journal of molecular sciences.

Long-term survival after allogeneic haematopoietic cell transplantation for AML in remission: single-centre results after TBI-based myeloablative and non-myeloablative conditioning

H. Sengeløv, T. Gerds, P. Brændstrup, 2013, Bone Marrow Transplantation.

Improved outcomes after allogenic hematopoietic stem cell transplantation with Fludarabine/Treosulfan for patients with myelodysplastic syndromes.

J. W. Hansen, H. Sengeløv, K. Grønbæk, 2020, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Syngeneic transplantation in aplastic anemia: pre-transplant conditioning and peripheral blood are associated with improved engraftment: an observational study on behalf of the Severe Aplastic Anemia and Pediatric Diseases Working Parties of the European Group for Blood and Marrow Transplantation

A. Ganser, N. Kröger, H. Sengeløv, 2013, Haematologica.

Haematopoietic stem cell transplantation with non‐myeloablative conditioning in the outpatient setting: results, complications and admission requirements in a single institution

H. Sengeløv, A. Svejgaard, L. Ryder, 2004, British journal of haematology.

Ocular Chronic Graft-Versus-Host Disease and Its Relation to Other Organ Manifestations and Outcomes After Allogeneic Haematopoietic Cell Transplantation.

H. Sengeløv, H. O. Julian, Steffen Heegaard, 2022, Transplantation and cellular therapy.

Mobilization of granules in neutrophils from patients with myeloproliferative disorders

H. Sengeløv, L. Kjeldsen, N. Borregaard, 1993, European journal of haematology.

Pre-transplantation vitamin E levels and acute graft-versus-host disease after non-myeloablative allogeneic hematopoietic cell transplantation.

H. Sengeløv, N. Jørgensen, S. Ostrowski, 2022, Transplant Immunology.

Vitamin E and acute graft‐versus‐host disease after myeloablative allogeneic hematopoietic cell transplantation

H. Sengeløv, S. Ostrowski, L. Friis, 2020, European journal of haematology.

A comparison of T-, B- and NK-cell reconstitution following conventional or nonmyeloablative conditioning and transplantation with bone marrow or peripheral blood stem cells from human leucocyte antigen identical sibling donors

H. Sengeløv, P. Björk, L. Ryder, 2003, Bone Marrow Transplantation.

Pretransplantation vitamin A plasma levels and risk of acute graft-versus-host disease following allogeneic hematopoietic stem cell transplantation

H. Sengeløv, S. Ostrowski, L. Friis, 2019, Bone Marrow Transplantation.

Pre-Transplantation Plasma ST2 Level as a Prognostic Biomarker of 1-Year Non-Relapse Mortality in Allogeneic Hematopoietic Cell Transplantation.

H. Sengeløv, S. Ostrowski, L. Friis, 2022, Transplantation and Cellular Therapy.

Current outcome of HLA identical sibling versus unrelated donor transplants in severe aplastic anemia: an EBMT analysis

H. Sengeløv, M. Aljurf, J. Passweg, 2015, Haematologica.

[Allogeneic bone marrow transplantation].

H. Sengeløv, L. Vindeløv, B. Nielsen, 2003, Ugeskrift for laeger.

The Time Course of Development and Impact From Viral Resistance Against Ganciclovir in Cytomegalovirus Infection

J. Lundgren, H. Sengeløv, S. Sørensen, 2013, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

Pre-Transplant Prediction of Acute Graft-versus-Host Disease Using the Gut Microbiome

J. Lundgren, H. Sengeløv, C. MacPherson, 2022, Cells.

Ocular graft-versus-host disease and dry eye disease after paediatric haematopoietic stem cell transplantation - incidence and risk factors

H. Sengeløv, V. Siersma, K. Müller, 2022, Bone Marrow Transplantation.

Thymic stromal lymphopoietin levels after allogeneic hematopoietic stem cell transplantation

H. Sengeløv, A. Pedersen, L. Ryder, 2022, Immunopharmacology and immunotoxicology.

Classification of death causes after transplantation (CLASS)

A. Mocroft, J. Lundgren, H. Sengeløv, 2017, Medicine.

Classi fi cation of death causes after transplantation ( CLASS ) Evaluation of methodology and initial results

A. Mocroft, J. Lundgren, H. Sengeløv, 2018 .

Physical and emotional well‐being of survivors of childhood and young adult allo‐SCT – A Danish national cohort study

H. Sengeløv, K. Christensen, L. Adamsen, 2016, Pediatric transplantation.

Isolation and primary structure of NGAL, a novel protein associated with human neutrophil gelatinase.

H. Sengeløv, L. Kjeldsen, A. Johnsen, 1993, The Journal of biological chemistry.

Biosynthesis of granule proteins in normal human bone marrow cells. Gelatinase is a marker of terminal neutrophil differentiation.

B. Nielsen, M. Sehested, H. Sengeløv, 1995, Blood.

Granules and vesicles of human neutrophils. The role of endomembranes as source of plasma membrane proteins

H. Sengeløv, L. Kjeldsen, N. Borregaard, 1993, European journal of haematology.

Identification of neutrophil gelatinase-associated lipocalin as a novel matrix protein of specific granules in human neutrophils.

H. Sengeløv, L. Kjeldsen, D. Bainton, 1994, Blood.

Ca2+‐dependent translocation of cytosolic proteins to isolated granule subpopulations and plasma membrane from human neutrophils

H. Sengeløv, L. Kjeldsen, N. Borregaard, 1992, FEBS letters.

Treatment of poor graft function after allogeneic hematopoietic cell transplantation with a booster of CD34-selected cells infused without conditioning

H. Sengeløv, B. Askaa, L. Vindeløv, 2014, Bone Marrow Transplantation.

Impact of CMV PCR Blips in Recipients of Solid Organ and Hematopoietic Stem Cell Transplantation

A. Mocroft, J. Lundgren, H. Sengeløv, 2018, Transplantation direct.

Cytomegalovirus (CMV) Disease Despite Weekly Preemptive CMV Strategy for Recipients of Solid Organ and Hematopoietic Stem Cell Transplantation

A. Mocroft, J. Lundgren, H. Sengeløv, 2018, Open forum infectious diseases.

Chronic ocular graft-versus-host disease after allogeneic haematopoietic stem cell transplantation in Denmark – factors associated with risks and rates in adults according to conditioning regimen

H. Sengeløv, F. Eriksson, S. Heegaard, 2020, Bone Marrow Transplantation.

Isolation and characterization of gelatinase granules from human neutrophils.

H. Sengeløv, L. Kjeldsen, N. Borregaard, 1994, Blood.

Solid‐phase Synthesis of Chemotactic Peptides Using α‐Azido Acids

H. Sengeløv, M. Meldal, Christian W. Tornøe, 2000 .

Purification of lysozyme from human neutrophils, and development of an ELISA for quantification in cells and plasma.

H. Sengeløv, L. Kjeldsen, N. Borregaard, 1995, Leukemia.

Development and Dynamics of Cytomegalovirus UL97 Ganciclovir Resistance Mutations in Transplant Recipients Detected by Next-Generation Sequencing

J. Lundgren, H. Sengeløv, H. Hirsch, 2021, Open forum infectious diseases.

Clinical Application of Variation in Replication Kinetics During Episodes of Post-transplant Cytomegalovirus Infections

A. Mocroft, J. Lundgren, H. Sengeløv, 2015, EBioMedicine.

Comparison of outcomes after unrelated cord blood and unmanipulated haploidentical stem cell transplantation in adults with acute leukemia

J. Sierra, M. Labopin, H. Sengeløv, 2015, Leukemia.

Bone marrow mononuclear cell telomere length in acute myeloid leukaemia and high‐risk myelodysplastic syndrome

S. Bojesen, B. Nordestgaard, H. Sengeløv, 2019, European Journal of Haematology.

Associations of the gut microbiome and clinical factors with acute GVHD in allogeneic HSCT recipients.

R. Paredes, J. Lundgren, J. Reekie, 2020, Blood advances.

Improved survival after allogeneic transplantation for acute lymphoblastic leukemia in adults: a Danish population-based study

H. Sengeløv, M. Andersen, H. Marquart, 2021, Leukemia & lymphoma.

Severity and 90-day survival of SARS-CoV-2 infection among patients with haematological disorders

O. Kirk, H. Sengeløv, M. Severinsen, 2022, Acta oncologica.

T-Cell Chimerism Is Valuable in Predicting Early Mortality in Steroid-Resistant Acute Graft-versus-Host Disease after Myeloablative Allogeneic Cell Transplantation

H. Sengeløv, H. Madsen, L. Minculescu, 2014, Acta Haematologica.

Prognosis of Allogeneic Haematopoietic Stem Cell Recipients Admitted to the Intensive Care Unit: A Retrospective, Single-Centre Study

H. Sengeløv, Jonas Nielsen, A. Lindmark, 2015, Acta Haematologica.

Associations between gastrointestinal toxicity, micro RNA and cytokine production in patients undergoing myeloablative allogeneic stem cell transplantation.

H. Sengeløv, C. Nielsen, N. Heegaard, 2015, International immunopharmacology.

Epidemiology and Clinical Significance of Secondary and Therapy-Related Acute Myeloid Leukemia: A National Population-Based Cohort Study.

M. Nørgaard, H. Sengeløv, I. Dufva, 2015, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Allogeneic hematopoietic cell transplantation for severe aplastic anemia: similar long-term overall survival after transplantation with related donors compared to unrelated donors

H. Sengeløv, C. Heilmann, N. Jacobsen, 2016, Bone Marrow Transplantation.

Associations between levels of insulin-like growth factor 1 and sinusoidal obstruction syndrome after allogeneic haematopoietic stem cell transplantation

H. Sengeløv, A. Juul, A. Pedersen, 2017, Bone Marrow Transplantation.

Trends in survival and cure after allogeneic haematopoietic cell transplantation for acute myeloid leukaemia from 2000 to 2020: A Danish population‐based cohort study

H. Sengeløv, M. Severinsen, K. Theilgaard-Mönch, 2022, British journal of haematology.

Haematopoietic cell transplantation with non-myeloablative conditioning in Denmark: disease-specific outcome, complications and hospitalization requirements of the first 100 transplants

H. Sengeløv, A. Svejgaard, L. Ryder, 2008, Bone Marrow Transplantation.

Longitudinal follow-up of response status and concomitant immunosuppression in patients treated with extracorporeal photopheresis for chronic graft versus host disease

H. Sengeløv, T. Karlsmark, L. Friis, 2018, Bone Marrow Transplantation.

Extracorporeal photopheresis is a valuable treatment option in steroid-refractory or steroid-dependent acute graft versus host disease—experience with three different approaches

H. Sengeløv, T. Karlsmark, L. Friis, 2018, Bone Marrow Transplantation.

Stem Cell Transplantation for Diamond-Blackfan Anemia. A Retrospective Study on Behalf of the Severe Aplastic Anemia Working Party of the European Blood and Marrow Transplantation Group (EBMT).

H. Sengeløv, C. Niemeyer, A. Risitano, 2021, Transplantation and cellular therapy.

Effect of auranofin on human platelet aggregation, release of serotonin, and cyclic-AMP formation

H. Sengeløv, K. Winther, P. Oxholm, 1988, Inflammation.

Improved Relapse-Free Survival in Patients With High Natural Killer Cell Doses in Grafts and During Early Immune Reconstitution After Allogeneic Stem Cell Transplantation

H. Sengeløv, H. Marquart, L. Ryder, 2020, Frontiers in Immunology.

Mononuclear Cell Telomere Attrition Is Associated with Overall Survival after Nonmyeloablative Allogeneic Hematopoietic Cell Transplantation for Hematologic Malignancies.

S. Bojesen, B. Nordestgaard, H. Sengeløv, 2019, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Gut microbiome comparability of fresh-frozen versus stabilized-frozen samples from hospitalized patients using 16S rRNA gene and shotgun metagenomic sequencing

R. Paredes, J. Lundgren, H. Sengeløv, 2019, Scientific Reports.

Oral cyclosporine A treatment is feasible after myeloablative conditioning in allogeneic hematopoietic stem cell transplantation

H. Sengeløv, D. Hovgaard, L. Vindeløv, 2015, Journal of clinical pharmacy and therapeutics.

Molecular cloning and expression of a cDNA encoding NGAL: a lipocalin expressed in human neutrophils.

H. Sengeløv, L. Kjeldsen, N. Borregaard, 1994, Biochemical and biophysical research communications.

Impact of conditioning with TBI in adult patients with T-cell ALL who receive a myeloablative allogeneic stem cell transplantation: a report from the acute leukemia working party of EBMT

J. Esteve, M. Labopin, J. Finke, 2016, Bone Marrow Transplantation.

Epidemiology of bloodstream infections after myeloablative and non‐myeloablative allogeneic hematopoietic stem cell transplantation: A single‐center cohort study

H. Sengeløv, C. Moser, Lars I Gjaerde, 2017, Transplant infectious disease : an official journal of the Transplantation Society.

Biopsy-verified bronchiolitis obliterans and other noninfectious lung pathologies after allogeneic hematopoietic stem cell transplantation.

I. Christensen, H. Sengeløv, J. Mortensen, 2015, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Allogenic hematopoietic stem cell transplantation in two siblings with adult metachromatic leukodystrophy and a systematic literature review

C. Krarup, H. Sengeløv, J. Stokholm, 2021, JIMD reports.

Improved Overall Survival, Relapse-Free-Survival, and Less Graft-vs.-Host-Disease in Patients With High Immune Reconstitution of TCR Gamma Delta Cells 2 Months After Allogeneic Stem Cell Transplantation

J. Reekie, H. Sengeløv, H. Marquart, 2019, Front. Immunol..

The Role of Gamma Delta T Cells in Haematopoietic Stem Cell Transplantation

H. Sengeløv, L. Minculescu, 2015, Scandinavian journal of immunology.

Extramedullary Leukemia and Myeloid Sarcoma in AML: New Clues to an Old Issue. Results of a Retrospective Population-Based Registry-Study of 2261 patients

H. Johnsen, H. Sengeløv, L. Kjeldsen, 2011 .

Comorbidity and performance status in acute myeloid leukemia patients: a nation-wide population-based cohort study

M. Nørgaard, H. Sengeløv, I. Dufva, 2014, Leukemia.

Detection of the novel HLA allele, HLA‐DRB1*08:112, identified in a Danish family

H. Sengeløv, H. Bruunsgaard, A. Plesner, 2022, HLA.

EPIDEMIOLOGY OF HEPATITIS E VIRUS INFECTION IN A COHORT OF 4,023 IMMUNOCOMPROMISED PATIENTS.

H. Ullum, C. Hother, J. Lundgren, 2019, International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases.

Evaluation of infliximab as second-line treatment of acute graft versus host disease -validating response on day 7 and 28 as predictors of survival

H. Sengeløv, C. Moser, C. Heilmann, 2018, Bone Marrow Transplantation.

Single‐institution long‐term outcomes for patients receiving nonmyeloablative conditioning hematopoeitic cell transplantation for chronic lymphocytic leukemia and follicular lymphoma

H. Sengeløv, L. Vindeløv, B. K. Mortensen, 2012, European journal of haematology.

Risk Factors for Subsequent Central Nervous System Tumors in Pediatric Allogeneic Hematopoietic Cell Transplant: A Study from the Center for International Blood and Marrow Transplant Research (CIBMTR).

H. Sengeløv, Chi-kong Li, B. Shaw, 2017, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Less mucositis toxicity after 6 versus 3 fractions of high-dose total body irradiation before allogeneic stem cell transplantation

L. Specht, H. Sengeløv, P. M. Petersen, 2019, Bone Marrow Transplantation.

Title: Impact of Allogeneic Stem Cell Transplantation in First Complete Remission in Acute Myeloid Leukemia: a National Population-Based Cohort

M. Nørgaard, H. Sengeløv, J. Lund, 2017 .

Syddansk Universitet Impact of Allogeneic Stem Cell Transplantation in First Complete Remission in Acute Myeloid Leukemia a National Population-Based Cohort Study

M. Nørgaard, H. Sengeløv, J. Lund, 2017 .

Development and validation of a cycle‐specific risk score for febrile neutropenia during chemotherapy cycles 2–6 in patients with solid cancers: The CSRFENCE score

A. Mocroft, J. Lundgren, L. Specht, 2020, International journal of cancer.

Development and validation of a cycle-speci ﬁ c risk score for febrile neutropenia during chemotherapy cycles 2 – 6 in patients with solid cancers: The CSR FENCE score

A. Mocroft, J. Lundgren, J. Reekie, 2019 .

Development and Validation of a Risk Score for Febrile Neutropenia After Chemotherapy in Patients With Cancer: The FENCE Score

A. Mocroft, J. Lundgren, L. Specht, 2018, JNCI cancer spectrum.

ProHNPs are specific markers of normal myelopoiesis

H. Sengeløv, N. Borregaard, P. Kampmann, 2014, Blood Cancer Journal.

Addition of plerixafor for CD34+ cell mobilization in six healthy stem cell donors ensured satisfactory grafts for transplantation

H. Sengeløv, E. Dickmeiss, A. Fischer-Nielsen, 2014, Transfusion.

(GT)n Repeat Polymorphism in Heme Oxygenase-1 (HO-1) Correlates with Clinical Outcome after Myeloablative or Nonmyeloablative Allogeneic Hematopoietic Cell Transplantation

H. Sengeløv, T. Klausen, P. Brændstrup, 2016, PloS one.

Association of HMGB1 polymorphisms with outcome after allogeneic hematopoietic cell transplantation.

H. Sengeløv, P. Garred, K. Müller, 2009, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Insulin‐like growth factor‐1 and insulin‐like growth factor binding protein‐3: impact on early haematopoietic reconstitution following allogeneic haematopoietic stem cell transplantation

H. Sengeløv, A. Juul, C. Nielsen, 2021, European journal of haematology.

[Allogeneic haematopoietic cell transplantation with nonmyeloablative conditioning in Denmark].

H. Sengeløv, H. Madsen, L. Vindeløv, 2010, Ugeskrift for laeger.

“Risk of de novo or secondary cancer after solid organ or allogeneic haematopoietic stem cell transplantation”

A. Mocroft, J. Lundgren, H. Sengeløv, 2019, Journal of Cancer Research and Clinical Oncology.

Evaluation of an electronic, patient‐focused management system aimed at preventing cytomegalovirus disease following solid organ transplantation

J. Lundgren, J. Reekie, H. Sengeløv, 2020, Transplant infectious disease : an official journal of the Transplantation Society.

Classification of Death Causes after Transplantation (CLASS): Evaluation of Methodology and Initial Results

A. Mocroft, J. Lundgren, H. Sengeløv, 2017 .

SARS‐CoV‐2 infection among patients with haematological disorders: Severity and one‐month outcome in 66 Danish patients in a nationwide cohort study

O. Kirk, H. Sengeløv, M. Severinsen, 2020, European journal of haematology.

Mortality and admission to intensive care units after febrile neutropenia in patients with cancer

A. Mocroft, J. Lundgren, L. Specht, 2020, Cancer medicine.

Granules and Secretory Vesicles in Human Neonatal Neutrophils

H. Sengeløv, L. Kjeldsen, N. Borregaard, 1996, Pediatric Research.

Incidence Rates and Risk Factors of Clostridioides difficile Infection in Solid Organ and Hematopoietic Stem Cell Transplant Recipients

Mark P Khurana, A. Mocroft, J. Lundgren, 2019, Open forum infectious diseases.

Gut decontamination during allogeneic hematopoietic stem cell transplantation and the risk of acute graft-versus-host disease

H. Sengeløv, Mette Schmidt, L. K. Gjærde, 2018, Bone Marrow Transplantation.

Febrile Neutropenia and Long-term Risk of Infection Among Patients Treated With Chemotherapy for Malignant Diseases

J. Lundgren, H. Sengeløv, G. Daugaard, 2018, Open forum infectious diseases.

Gastrointestinal Toxicity, Systemic Inflammation, and Liver Biochemistry in Allogeneic Hematopoietic Stem Cell Transplantation.

D. Burrin, M. H. Jørgensen, I. Christensen, 2017, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Prognostic significance of liver parameters at 1-year follow-up in children and adults undergoing myeloablative allogeneic stem cell transplantation

M. H. Jørgensen, I. Christensen, H. Sengeløv, 2015, Bone Marrow Transplantation.

Cytokine autoantibodies are stable throughout the haematopoietic stem cell transplantation course and are associated with distinct biomarker and blood cell profiles

H. Sengeløv, S. Ostrowski, M. Hansen, 2021, Scientific Reports.

Granulocyte Colony-Stimulating Factor Effectively Mobilizes TCR γδ and NK Cells Providing an Allograft Potentially Enhanced for the Graft-Versus-Leukemia Effect for Allogeneic Stem Cell Transplantation

H. Sengeløv, H. Marquart, L. Ryder, 2021, Frontiers in Immunology.

Pulmonary function is a strong predictor of 2‐year overall survival and non‐relapse mortality after allogenic hematopoietic cell transplantation

H. Sengeløv, J. Mortensen, L. Friis, 2022, European journal of haematology.

Triple-drug GVHD prophylaxis after HLA-matched unrelated donor non-myeloablative allogenic hematopoietic stem cell transplantation.

H. Sengeløv, L. Friis, N. Andersen, 2023, Transplantation and cellular therapy.

Higher recipient pre‐transplant FOXP3 mRNA expression is associated with acute leukaemia relapse after HSCT

N. Keiding, H. Sengeløv, L. Ryder, 2022, EJHaem.

Iron status markers in patients with small cell carcinoma of the lung. Relation to survival.

N. Milman, H. Sengeløv, P. Dombernowsky, 1991, British Journal of Cancer.

Impact of antibiotic treatment on the gut microbiome and its resistome in hematopoietic stem cell transplant recipients.

H. Sengeløv, C. MacPherson, R. Z. Marandi, 2023, The Journal of infectious diseases.

Impact Of Comorbidity and Performance Status On Treatment Intent and Outcome In AML Patients. A Danish Population-Based Cohort Study

M. Nørgaard, H. Sengeløv, J. Nørgaard, 2013 .

Impact of chemotherapy delay on short- and long-term survival in younger and older AML patients: a Danish population-based cohort study

M. Nørgaard, H. Sengeløv, M. Jensen, 2014, Leukemia.

Impact of Allogeneic Stem Cell Transplantation in First Complete Remission in Acute Myeloid Leukemia: A National Population-Based Cohort Study.

M. Nørgaard, H. Sengeløv, J. Lund, 2018, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

[Allogeneic haematopoietic cell transplantation with nonmyeloablative conditioning in Denmark].

H. Sengeløv, H. Madsen, L. Vindeløv, 2010, Ugeskrift for laeger.

Human neutrophils are devoid of the integral membrane protein caveolin

H. Sengeløv, J. Vinten, N. Borregaard, 1998, Journal of leukocyte biology.

Factors associated with the development of cytomegalovirus infection following solid organ transplantation

Z. Fox, J. Lundgren, H. Sengeløv, 2011, Scandinavian journal of infectious diseases.

The Role of Gamma Delta T Cells in Haematopoietic Stem Cell Transplantation

H. Sengeløv, L. Minculescu, 2015, Scandinavian journal of immunology.

Do Results From Clinical Trials in Acute Myeloid Leukemia Reflect Clinical Reality? A Danish National Cohort Study of 813 Patients

M. Nørgaard, H. Sengeløv, L. Kjeldsen, 2012 .

Complement receptors in neutrophils.

H. Sengeløv, H. Sengeløv, 1995, Critical reviews in immunology.

Metabolic Profiling Early Post-Allogeneic Haematopoietic Cell Transplantation in the Context of CMV Infection

H. Sengeløv, C. MacPherson, S. Brix, 2023, Metabolites.